Moleculin Biotech, Inc. — Director's Dealing 2017

Apr 26, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2017-04-25

Reporting Person: Foster Jonathan P. (Exec. Vice President & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-25	Common Stock	P	10000	$0.8649	Acquired	10000	Direct